UPMC CancerCenter — Pittsburgh, Pennsylvania

Public research footprint of UPMC CancerCenter, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Unresectable or Metastatic Solid Tumors · Cancer of the Ovary · Metastatic Merkel Cell Carcinoma · PD-L1 Amplified Tumor (9p24.1)

Recently updated registry entries

NCT02432378 — Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC… (Withdrawn)
NCT06873789 — A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid… (Active Not Recruiting)
NCT06188559 — A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UPMC CancerCenter?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.